Logo image of SNEX

STONEX GROUP INC (SNEX) Stock Fundamental Analysis

NASDAQ:SNEX - Nasdaq - US8618961085 - Common Stock - Currency: USD

86.28  -1.86 (-2.12%)

After market: 86.28 0 (0%)

Fundamental Rating

3

Overall SNEX gets a fundamental rating of 3 out of 10. We evaluated SNEX against 230 industry peers in the Capital Markets industry. SNEX has a bad profitability rating. Also its financial health evaluation is rather negative. SNEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

SNEX had positive earnings in the past year.
In the past year SNEX has reported a negative cash flow from operations.
Each year in the past 5 years SNEX has been profitable.
The reported operating cash flow has been mixed in the past 5 years: SNEX reported negative operating cash flow in multiple years.
SNEX Yearly Net Income VS EBIT VS OCF VS FCFSNEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of SNEX (0.91%) is worse than 68.26% of its industry peers.
SNEX's Return On Equity of 15.19% is fine compared to the rest of the industry. SNEX outperforms 77.39% of its industry peers.
The Return On Invested Capital of SNEX (1.52%) is worse than 66.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SNEX is significantly below the industry average of 7.27%.
Industry RankSector Rank
ROA 0.91%
ROE 15.19%
ROIC 1.52%
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
SNEX Yearly ROA, ROE, ROICSNEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 0.23%, SNEX is not doing good in the industry: 73.48% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of SNEX has remained more or less at the same level.
With a Operating Margin value of 0.32%, SNEX is not doing good in the industry: 72.17% of the companies in the same industry are doing better.
SNEX's Operating Margin has been stable in the last couple of years.
SNEX has a Gross Margin of 1.97%. This is in the lower half of the industry: SNEX underperforms 70.87% of its industry peers.
SNEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.32%
PM (TTM) 0.23%
GM 1.97%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
SNEX Yearly Profit, Operating, Gross MarginsSNEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, SNEX has more shares outstanding
Compared to 5 years ago, SNEX has more shares outstanding
The debt/assets ratio for SNEX is higher compared to a year ago.
SNEX Yearly Shares OutstandingSNEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
SNEX Yearly Total Debt VS Total AssetsSNEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 3.67 indicates that SNEX is not in any danger for bankruptcy at the moment.
SNEX has a Altman-Z score of 3.67. This is amongst the best in the industry. SNEX outperforms 80.43% of its industry peers.
SNEX has a Debt/Equity ratio of 7.19. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 7.19, SNEX is not doing good in the industry: 86.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 7.19
Debt/FCF N/A
Altman-Z 3.67
ROIC/WACCN/A
WACCN/A
SNEX Yearly LT Debt VS Equity VS FCFSNEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SNEX has a Current Ratio of 0.52. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.52, SNEX is doing worse than 73.91% of the companies in the same industry.
SNEX has a Quick Ratio of 0.52. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SNEX (0.52) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
SNEX Yearly Current Assets VS Current LiabilitesSNEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.07% over the past year.
The Earnings Per Share has been growing by 22.13% on average over the past years. This is a very strong growth
The Revenue has grown by 67.71% in the past year. This is a very strong growth!
SNEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.87% yearly.
EPS 1Y (TTM)18.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%29.75%
Revenue 1Y (TTM)67.71%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%49.48%

3.2 Future

The Earnings Per Share is expected to grow by 8.25% on average over the next years. This is quite good.
SNEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.46% yearly.
EPS Next Y12%
EPS Next 2Y6.15%
EPS Next 3Y8.25%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y6.13%
Revenue Next 3Y5.46%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNEX Yearly Revenue VS EstimatesSNEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
SNEX Yearly EPS VS EstimatesSNEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.62, which indicates a correct valuation of SNEX.
Compared to the rest of the industry, the Price/Earnings ratio of SNEX is on the same level as its industry peers.
SNEX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.03.
A Price/Forward Earnings ratio of 14.43 indicates a correct valuation of SNEX.
The rest of the industry has a similar Price/Forward Earnings ratio as SNEX.
When comparing the Price/Forward Earnings ratio of SNEX to the average of the S&P500 Index (21.94), we can say SNEX is valued slightly cheaper.
Industry RankSector Rank
PE 14.62
Fwd PE 14.43
SNEX Price Earnings VS Forward Price EarningsSNEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

91.74% of the companies in the same industry are more expensive than SNEX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.89
SNEX Per share dataSNEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.22
PEG (5Y)0.66
EPS Next 2Y6.15%
EPS Next 3Y8.25%

0

5. Dividend

5.1 Amount

No dividends for SNEX!.
Industry RankSector Rank
Dividend Yield N/A

STONEX GROUP INC

NASDAQ:SNEX (5/21/2025, 8:00:02 PM)

After market: 86.28 0 (0%)

86.28

-1.86 (-2.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners81.71%
Inst Owner Change55.36%
Ins Owners9.72%
Ins Owner Change11.84%
Market Cap4.15B
Analysts87.5
Price Target84.66 (-1.88%)
Short Float %3.06%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.79%
Min EPS beat(2)4.76%
Max EPS beat(2)14.81%
EPS beat(4)4
Avg EPS beat(4)8.49%
Min EPS beat(4)3.43%
Max EPS beat(4)14.81%
EPS beat(8)8
Avg EPS beat(8)11.57%
EPS beat(12)11
Avg EPS beat(12)13.14%
EPS beat(16)13
Avg EPS beat(16)15.34%
Revenue beat(2)2
Avg Revenue beat(2)1.2%
Min Revenue beat(2)0.48%
Max Revenue beat(2)1.92%
Revenue beat(4)3
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-3.69%
Max Revenue beat(4)6.22%
Revenue beat(8)5
Avg Revenue beat(8)-1.53%
Revenue beat(12)9
Avg Revenue beat(12)1100.01%
Revenue beat(16)13
Avg Revenue beat(16)1890.17%
PT rev (1m)-2.73%
PT rev (3m)-30.25%
EPS NQ rev (1m)-1.22%
EPS NQ rev (3m)-38.92%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-33.02%
Revenue NQ rev (1m)0.68%
Revenue NQ rev (3m)3.7%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)7.93%
Valuation
Industry RankSector Rank
PE 14.62
Fwd PE 14.43
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 2.21
P/tB 2.32
EV/EBITDA 7.89
EPS(TTM)5.9
EY6.84%
EPS(NY)5.98
Fwd EY6.93%
FCF(TTM)-23.39
FCFYN/A
OCF(TTM)-22.06
OCFYN/A
SpS2556.3
BVpS39.1
TBVpS37.23
PEG (NY)1.22
PEG (5Y)0.66
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 15.19%
ROCE 6.01%
ROIC 1.52%
ROICexc 1.63%
ROICexgc 1.75%
OM 0.32%
PM (TTM) 0.23%
GM 1.97%
FCFM N/A
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
ROICexc(3y)2.29%
ROICexc(5y)1.95%
ROICexgc(3y)2.5%
ROICexgc(5y)2.13%
ROCE(3y)6.36%
ROCE(5y)5.86%
ROICexcg growth 3Y11.83%
ROICexcg growth 5Y4.45%
ROICexc growth 3Y11.82%
ROICexc growth 5Y4.25%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
F-Score4
Asset Turnover3.93
Health
Industry RankSector Rank
Debt/Equity 7.19
Debt/FCF N/A
Debt/EBITDA 27.95
Cap/Depr 72.81%
Cap/Sales 0.05%
Interest Coverage 0.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 3.67
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)80.55%
Cap/Depr(5y)85.05%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%29.75%
EPS Next Y12%
EPS Next 2Y6.15%
EPS Next 3Y8.25%
EPS Next 5YN/A
Revenue 1Y (TTM)67.71%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%49.48%
Revenue Next Year9.72%
Revenue Next 2Y6.13%
Revenue Next 3Y5.46%
Revenue Next 5YN/A
EBIT growth 1Y20.39%
EBIT growth 3Y31.11%
EBIT growth 5Y26.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.25%
FCF growth 3Y-40.15%
FCF growth 5Y19.18%
OCF growth 1Y63.81%
OCF growth 3Y-37.96%
OCF growth 5Y20.98%